Apraglutide TFA FE 203799 TFA|西域试剂

Apraglutide TFA FE 203799 TFA

产品编号：Bellancom-P1714A| 分子式：C₁₇₂H₂₆₃N₄₃O₅₂.C₂HF₃O₂| 分子量：3879.27

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	价格	库存与货期
Bellancom-P1714A	￥1200.00	杭州北京（现货）
Bellancom-P1714A	￥3300.00	杭州北京（现货）
Bellancom-P1714A	￥5200.00	杭州北京（现货）
Bellancom-P1714A	￥9800.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

Apraglutide TFA FE 203799 TFA

产品介绍

Apraglutide TFA (FE 203799 TFA) 是一种合成的33-氨基酸肽和长效的 GLP-2类似物，能够增强全回肠切除的新生短肠综合征小猪的适应性和线性肠生长。

生物活性

Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.

体外研究

体内研究

Apraglutide (FE 203799; 5 mg/kg/dose, subcutaneously, twice on days 0 and 4 postsurgery) treated piglets are healthy, have significant lower fecal fat and energy losses and exhibite intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth on day 7.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	NewbornDuroc piglets, 2-5 days old and weighing between 2-2.6 kg.
Dosage:	5 mg/kg/dose.
Administration:	Subcutaneously, twice on days 0 and 4 postsurgery.
Result:	On day 7, treated piglets were healthy, had significant lower fecal fat and energy losses and exhibited intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth.

体内研究

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	NewbornDuroc piglets, 2-5 days old and weighing between 2-2.6 kg.
Dosage:	5 mg/kg/dose.
Administration:	Subcutaneously, twice on days 0 and 4 postsurgery.
Result:	On day 7, treated piglets were healthy, had significant lower fecal fat and energy losses and exhibited intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth.